NS

Naveed Siddiqi

Senior Partner at Novo Holdings

United Kingdom

Overview 

Naveed Siddiqi is a Senior Partner at Novo Holdings in the United Kingdom, with a strong background in venture financing and portfolio management. He has held board positions in various healthcare and biotech companies, showcasing his expertise in corporate development and strategic leadership. Siddiqi's career highlights include his roles as a Partner at Andera Partners and his involvement in multiple healthcare and biotech boards, demonstrating a track record of successful investments and strategic leadership in the industry.

Work Experience 

NH

Novo Holdings

  • Senior Partner

    2021 - Current

    Naveed is a member of Ventures Investment leadership team. Naveed is also a member of the Investment Committee for Novo Holdings Asia PTE.

  • Partner

    2019

    Novo Holdings is a company wholly owned by the Novo Nordisk Foundation. It is the holding and investment company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Novo Nordisk Foundation’s assets. Novo Holdings is recognized as a one of the world's largest international life science investors, with a focus on creating long- term value. Novo Holdings provides seed and venture capital to development- stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings manages $13 billion of life science investments.

AS

Asceneuron SA

  • Board Member

    2024

AT

Alentis Therapeutics

  • Board Member

    2023

NT

Numab Therapeutics AG

  • Board Observer

    2021

B(

BGV (BioGeneration Ventures)

  • LP Advisory Committee Member

    2021

F

F2G

  • Board Member

    2020

AP

Amolyt Pharma

  • Board Member

    2020 - 2024

R

ReViral

  • Board Member

    2021 - 2022

VectivBio AG

  • Board Member

    2020 - 2021

AP

Andera Partners

  • Partner

    2013 - 2018

    Partner - life sciences at Andera Partners (formerly Edmond de Rothschild Investment Partners). The life sciences team of Andera Partners is a highly experienced and leading investor in therapeutic and medical technology companies. Andera Partners has over €2bn under management across European growth equity and global life sciences.

Education 

Articles About Naveed

Relevant Websites